T1	p 928 934	United
T2	p 1097 1265	General surgical patients including those undergoing noncardiac thoracic and pelvic operations who were identified at moderate to high risk for postop DVT were included
T3	p 1456 1551	Eight hundred and eighty eight patients were entered into this trial and 744 ( 85 % ) completed
T4	i 547 564	dihydroergotamine
T5	i 567 570	DHE
T6	i 982 1096	DHE 0.5 mg plus heparin 5000 U , DHE 0.5 mg plus heparin 2500 U , heparin 5000 U , and DHE 0.5 mg versus placebo .
T7	i 1645 1652	placebo
T8	o 774 799	venous endothelial injury